Recent news on Nabi-Hb

Value Find: Nabi Biopharmaceuticals  -  May 24, 2007
SmallCapInvestorNabi Biologics is responsible for the company’s protein and immunological products and development pipeline, with its core drug today being Nabi-HB.

Nabi Biopharmaceuticals Announces Agreement to Sell Aloprim  -  Apr 20, 2007
PharmaLive.com (press release),Nabi Biologics will have responsibility for the company's protein and immunological products and development pipeline, including Nabi-HB.

Nabi to sell drug to Irish pharmaceutical firm  -  Apr 20, 2007
Charlotte Business Journal,The Aloprim sale leaves it with a single drug on the market, Nabi-HB, for hepatitis B. Nabi's board in February replaced Tom McLain, its president,

Business Topics by Industry  -  Apr 20, 2007
Sun-Sentinel.com,With its sale, Nabi will have one product left on the market -- Nabi-HB to treat patients exposed to hepatitis B. A business opportunities workshop with the

Nabi Biopharmaceuticals Files Form 10-K and Corrects Financial Tables  -  Apr 6, 2007
Drug Newswire (press release),The company has two products on the market today: Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], and Aloprim(TM) (allopurinol sodium) for Injection.

Nabi Biopharmaceuticals Announces Fourth Quarter and Full-Year ...  -  Mar 12, 2007
PR Newswire (press release),Nabi Biologics will have responsibility for the company's protein and immunological products and development pipeline, including Nabi-HB.

Nabi Biopharmaceuticals Files Form 10-K and Corrects Financial Tables  -  Mar 16, 2007
PharmaLive.com (press release),The company has two products on the market today: Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], and Aloprim(TM) (allopurinol sodium) for Injection.

Nabi logs losses, details structure changes  -  Mar 13, 2007
Bizjournals.com,The company credited that 54 percent revenue rise to strong sales of Nabi-HB, a hepatitis B treatment, which totaled $11.5 million, as well as a $4.5

Aftermarket Movers: Jo-Ann, Panacos  -  Mar 12, 2007
Forbes,The company said it saw strong revenue from its Hepatitis B treatment, Nabi-HB. The company also said it plans to restructure operations into two separate

Nabi Biopharmaceuticals to Announce 2006 Fourth Quarter and Year ...  -  Feb 21, 2007
PR Newswire (press release),The company has two products on the market today: Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], and Aloprim(TM) (allopurinol sodium) for Injection.

Nabi Biopharmaceuticals Announces Resignation of Thomas McLain as ...  -  Feb 16, 2007
PharmaLive.com (press release),In addition, Nabi announced that unaudited sales of Nabi-HB(R) [Hepatitis B Immune Globulin (Human)] were in excess of $11.0 million in the fourth quarter

Beleaguered Nabi CEO McLain resigns  -  Feb 19, 2007
Boca Raton News,With the announcement of McLain’s resignation, Nabi also announced that unaudited sales of Nabi-HB(R) [Hepatitis B Immune Globulin (Human)] were in excess

New era begins at Nabi as interim CEO takes over  -  Feb 16, 2007
Palm Beach Post,In a news release, Nabi did say that unaudited sales of Nabi HB, a treatment for those exposed to hepatitis B and one of only two Nabi drugs on the market,

Nabi Biopharmaceuticals Announces Initiation Of Civacir(R) Phase ...  -  Jan 17, 2007
Medical News Today (press release),The company has two products on the market today: Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], and Aloprim(TM) (allopurinol sodium) for Injection.

Nabi survives year of tumult, but future still cloudy  -  Dec 2, 2006
Palm Beach Post,They're completely separate," Shrader said. Shrader also thinks Nabi won't sell the Boca plant without also selling Nabi-HB, which is made there. ...

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional